Yes, but protective UVA-blocking eyewear is recommended on treatment days to prevent ocular phototoxicity. Consult your ophthalmologist for appropriate lens specifications.
The tablet should be swallowed about 2 hours prior to the scheduled UVA exposure to allow optimal systemic absorption.
The 10 mg methoxsalen tablet is typically white, round, and may bear a unique imprint code that varies by manufacturer.
It is permissible to travel with a prescription-only medication, provided you carry the original prescription and a copy of the medication label. Check the destination country's regulations before departure.
Moderate alcohol intake is generally acceptable, but excessive consumption may increase nausea and reduce tolerance to phototoxic reactions.
No specific foods are prohibited, but taking the tablet with a light meal can lessen stomach upset.
An annual comprehensive eye examination is advised, with additional checks if you notice visual changes such as glare or blurred vision.
Although some studies have examined psoralen-UVA for atopic dermatitis, Ox soralen is not approved for eczema treatment in the UK. Use only under specialist supervision if considered off-label.
Methoxsalen is not screened for in standard workplace drug tests and is unlikely to cause a positive result.
The medication remains stable until the printed expiration date, provided it is stored in a cool, dry place away from light. Discard any tablets that appear discoloured or damaged before that date.
Ox soralen is a prescription-only medication (POM) marketed in the United Kingdom. It contains methoxsalen as its active component and is supplied as a 10 mg oral pill. Methoxsalen belongs to the psoralen class of drugs and is used primarily in combination with controlled exposure to ultraviolet A (UVA) light. The formulation is intended for dermatological conditions that respond to phototherapy.
Methoxsalen intercalates into DNA strands. When the skin is subsequently exposed to UVA light, the drug becomes activated and forms covalent bonds (cross-links) between DNA bases. This photochemical reaction slows the rapid proliferation of skin cells and reduces abnormal pigmentation. The effect is localized to the treated skin area, making methoxsalen a useful sensitizer for PUVA (psoralen + UVA) therapy.
In the UK, Ox soralen is approved for use in PUVA therapy to treat:
The medication is prescribed by dermatologists who supervise the phototherapy sessions.
Research has explored methoxsalen for other skin disorders, such as lichen planus and certain cutaneous T-cell lymphomas. These applications are not approved by the MHRA and should only be considered when a qualified dermatologist judges the potential benefits to outweigh the risks. Off-label use requires close medical supervision and individualized risk assessment.
Absolute contraindications
Relative contraindications
This article provides educational information about Ox soralen and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.